Skip to content

Remote Hypertension Management for Black Patients

Remote Hypertension Tracking, Help, and Management to Reduce Disparities in Black Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06527794
Acronym
RHYTHM-B
Enrollment
864
Registered
2024-07-30
Start date
2024-12-13
Completion date
2028-09-01
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncontrolled Hypertension

Keywords

high blood pressure, African-American population, remote blood pressure monitoring

Brief summary

This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and a community health worker. The other approach will include usual clinic-based care along with a home BP monitor and routine care.

Detailed description

This study is a pragmatic effectiveness-implementation hybrid type 2 trial with two study arms. One arm will include home BP telemonitoring supported by a pharmacist and a community health worker providing centralized self-management support. The other arm will include enhanced usual clinic-based care with a home BP monitor and routine care from providers trained on evidence-based guidelines.

Interventions

BEHAVIORALRHYTHM (Remote Hypertension Tracking Help Management)

Home blood pressure telemonitoring with remote medication management by a centralized multidisciplinary team led by a pharmacist; and social support, lifestyle education and connection to community resources to address social needs, provided by a community health worker who is embedded with the centralized team and is tightly connected to community resources and partners

BEHAVIORALEnhanced usual care (UC)

All participating sites will receive training on appropriate blood pressure measurement and education on guideline-based hypertension therapy. Additionally, participants in usual care will receive a standardized packet with evidence-based hypertension education material and a blood pressure monitor to complete blood pressure measurements at home.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Black or African American race * Hypertension diagnosis * aged 21 to 85 years * Uncontrolled blood pressure as defined by \[a\] most recent SBP ≥140 mmHg and an additional SBP≥140 mmHg within the past 12 months in an outpatient setting (excluding urgent care, emergency department or surgery clinic), or \[b\] most recent SBP\>160mmHg in an outpatient setting (excluding urgent care, emergency department or surgery clinic), or \[c\] referral by PCP for uncontrolled hypertension with at least one documented SBP≥140 mmHg (in clinic or at home) in the past 12 months; and (v) primary care provided at a participating clinic. * Able to speak English * Primary care provided at a participating clinic

Exclusion criteria

* currently pregnant or planning to get pregnant during the study period * residence in a long-term care facility, hospice or with a terminal illness with less than 1 year life expectancy as determined by the Primary Care Physician or study team. Stable chronic illness such as compensated cirrhosis, chronic obstructive pulmonary disease, congestive heart failure etc. will not be excluded. * estimated Glomerular Filtration Rate (eGFR) \<30 ml/min or on dialysis. Patients with a functioning kidney transplant will not be excluded. * inability to provide informed consent or participate in study procedures. For example, conditions that limit ability to participate in phone visits or check BPs in at least one arm. * currently participating in another BP management program. * plan to move out of the area within the next 12 months. * Hispanic ethnicity.

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure control - Percent of patients achieving BP control (i.e., Systolic BP<130mmHg) - Month 12Month 12Percent of patients achieving BP control (i.e., SBP\<130mmHg)

Secondary

MeasureTime frameDescription
Blood pressure control - Percent of patients achieving BP control (i.e., Systolic BP<130mmHg) - BaselineBaselinePercent of patients achieving BP control (i.e., SBP\<130mmHg)
Blood pressure control - Percent of patients achieving BP control (i.e., Systolic BP<130mmHg) - Month 6Month 6Percent of patients achieving BP control (i.e., SBP\<130mmHg)
Blood pressure control - Percent of patients achieving BP control (i.e., Systolic BP<130mmHg) - Month 18Month 18Percent of patients achieving BP control (i.e., SBP\<130mmHg)
Systolic blood pressure (mmHg) - BaselineBaselineMean SBP (mmHg)
Systolic blood pressure (mmHg) - Month 6Month 6Mean SBP (mmHg)
Systolic blood pressure (mmHg) - Month 12Month 12Mean SBP (mmHg)
Systolic blood pressure (mmHg) - Month 18Month 18Mean SBP (mmHg)
Self-Management - Hypertension Self-Care Profile Score - BaselineBaselineThe hypertension self-care profile score encompassed self-care behaviors crucial to control blood pressure - Includes 3 scales (Behavior, Motivation, Self-efficacy) 20 items each that can be used together or independently. The Behavior scale assesses participant's self-care behaviors on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care behavior. The Motivation scale assesses participant's self-care motivation on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care motivation. The Self-efficacy scale assesses participant's self-care efficacy on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-efficacy. Higher scores indicate better self care behaviors - range from 60-240.
Self-Management - Hypertension Self-Care Profile Score - Month 12Month 12The hypertension self-care profile score encompassed self-care behaviors crucial to control blood pressure - Includes 3 scales (Behavior, Motivation, Self-efficacy) 20 items each that can be used together or independently. The Behavior scale assesses participant's self-care behaviors on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care behavior. The Motivation scale assesses participant's self-care motivation on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care motivation. The Self-efficacy scale assesses participant's self-care efficacy on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-efficacy. Higher scores indicate better self care behaviors - range from 60-240.
Medication adherence - Hill-Bone medication adherence scale survey score - BaselineBaselineHill-Bone medication adherence scale survey - 14-item Hill-Bone Compliance Scale uses a 4-point Likert scale. Score range from 14-56. Higher scores indicates poorer adherence.
Medication adherence - Hill-Bone medication adherence scale survey score - Month 12Month 12Hill-Bone medication adherence scale survey - 14-item Hill-Bone Compliance Scale uses a 4-point Likert scale. Score range from 14-56. Higher scores indicates poorer adherence.
Patient assessment of chronic illness care (PACIC) survey score - BaselineBaselineThe Patient assessment of chronic illness care (PACIC) survey assess implementation of the chronic care model from the patient perspective. The PACIC includes five subscales addressing specific domains: (1) patient activation; (2) delivery system design/decision support; (3) goal setting/tailoring; (4) problem solving/contextual counselling; and (5) follow-up/coordination. Patients rated care received from their healthcare team (e.g., physicians, nurses, physiotherapists, occupational therapists, social workers) during the past 6-months using a 5-point Likert scale (1 = 'never' to 5 = 'always'). Total and subscale scores (i.e., summed items completed within that scale) are averaged across items.
Patient assessment of chronic illness care (PACIC) survey score - Month 12Month 12The Patient assessment of chronic illness care (PACIC) survey assess implementation of the chronic care model from the patient perspective. The PACIC includes five subscales addressing specific domains: (1) patient activation; (2) delivery system design/decision support; (3) goal setting/tailoring; (4) problem solving/contextual counselling; and (5) follow-up/coordination. Patients rated care received from their healthcare team (e.g., physicians, nurses, physiotherapists, occupational therapists, social workers) during the past 6-months using a 5-point Likert scale (1 = 'never' to 5 = 'always'). Total and subscale scores (i.e., summed items completed within that scale) are averaged across items.
20-Item Short Form Health Survey (SF-20) - BaselineBaselineThe SF-36 Total/Global/Overall Score, a global measure of health-related quality of life - scores range from 0-100 with higher scores denoting better quality of life
20-Item Short Form Health Survey (SF-20) - Month 12Month 12The SF-36 Total/Global/Overall Score, a global measure of health-related quality of life - scores range from 0-100 with higher scores denoting better quality of life
Healthcare Utilization - Number of Acute Care Days - BaselineBaselineTotal days spent in an emergency department, inpatient hospital, or observation unit; number of physician office visits.
Healthcare Utilization - Number of Acute Care Days - Month 12Month 12Total days spent in an emergency department, inpatient hospital, or observation unit; number of physician office visits.
Healthcare Utilization - Number of Acute Care Days - Month 24Month 24Total days spent in an emergency department, inpatient hospital, or observation unit; number of physician office visits.

Countries

United States

Contacts

CONTACTYhenneko J. Taylor, PhD
Yhenneko.Taylor@advocatehealth.org(704) 355-6562
CONTACTAsha Ganesan
asha.ganesan@advocatehealth.org
PRINCIPAL_INVESTIGATORYhenneko J. Taylor, PhD

Wake Forest University Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026